Clinical Pharmacist
Froedtert & the Medical College of Wisconsin
Evaluation of Lacosamide as Third-Line Therapy for Refractory Status Epilepticus
Tuesday, March 24, 2026
11:15 AM - 12:15 PM Central Time
Disclosure information not submitted.